PAK1 and PAK4 as therapeutic targets for Ewing sarcoma: a commentary

Ewing sarcoma (ES) is an aggressive pediatric bone tumor that is prone to metastasis. Due to low five-year survival rates and limited therapeutic options for metastatic disease, there is a dire clinical need for improved ES treatments. Targeting p21-activated kinases (PAKs) may be key. PAK1 and PAK4...

Descripción completa

Detalles Bibliográficos
Autores principales: Parks, Sydney E., Yustein, Jason T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802585/
https://www.ncbi.nlm.nih.gov/pubmed/36594908
http://dx.doi.org/10.46439/cancerbiology.2.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802585/
https://www.ncbi.nlm.nih.gov/pubmed/36594908
http://dx.doi.org/10.46439/cancerbiology.2.032

Ejemplares similares